Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
MB-105 by March Biosciences for Peripheral T-Cell Lymphomas (PTCL): Likelihood of Approval
MB-105 is under clinical development by March Biosciences and currently in Phase I for Peripheral T-Cell Lymphomas (PTCL). According to...
MB-105 by March Biosciences for Anaplastic Large Cell Lymphoma (ALCL): Likelihood of Approval
MB-105 is under clinical development by March Biosciences and currently in Phase I for Anaplastic Large Cell Lymphoma (ALCL). According...
MB-105 by Mustang Bio for Pancreatic Cancer: Likelihood of Approval
MB-105 is under clinical development by Mustang Bio and currently in Phase I for Pancreatic Cancer. According to GlobalData, Phase...